Description
Rekvina Laboratories Ltd. equity shares to be moved to 'X' group effective January 20, 2026.
Summary
BSE has announced that the equity shares of Rekvina Laboratories Ltd. (Scrip Code: 526075) will be moved to the ‘X’ group effective January 20, 2026. This group change is communicated to all trading members for compliance.
Key Points
- Rekvina Laboratories Ltd. (Scrip Code: 526075) to be included in ‘X’ group
- Effective date: January 20, 2026
- Notice issued to all trading members
- Contact persons: Mrs. Kinjal More (+91-7304278788), Yogendra Daxini (Deputy Vice President), Sonali Kurhade (Manager Listing Compliance)
Regulatory Changes
The equity shares of Rekvina Laboratories Ltd. will be transferred from their current group to the ‘X’ group. The ‘X’ group typically includes securities with special surveillance or restrictions due to regulatory concerns, compliance issues, or other market-related factors.
Compliance Requirements
- Trading members must note the group change and adjust their systems accordingly
- Trading in Rekvina Laboratories Ltd. shares must comply with ‘X’ group rules and restrictions from the effective date
- Members requiring clarification should contact the designated BSE officials
Important Dates
- Notice Date: January 13, 2026
- Effective Date: January 20, 2026
Impact Assessment
The movement to ‘X’ group will likely result in:
- Increased trading restrictions and surveillance on the stock
- Potential impact on liquidity due to stricter trading conditions
- Enhanced monitoring requirements for trading members
- Possible concerns among investors regarding the company’s compliance status
- Limited participation from certain categories of investors who may avoid ‘X’ group securities
Impact Justification
Movement to X group indicates regulatory concerns and imposes trading restrictions, affecting liquidity and investor access to the stock.